Valeant reports 4Q loss

Valeant reports 4Q loss


Valeant Pharmaceuticals International Inc. on Tuesday reported a fourth-quarter loss of $336.4 million, after reporting a profit in the same period a year earlier. The Laval, Quebec-based company said it had a loss of 98 cents per share.



from Biotech News